Alcon Recalls CyPass Micro-Stent Implant Due to Endothelial Cell Loss
Alcon is recalling the CyPass Micro-Stent implant because long-term study data showed statistically significant endothelial cell loss in patients who received the device.
What this means for you
Highest-severity recall. Risk of serious injury or death is documented or strongly suspected. Stop using the product now and follow the agency's instructions.
Our severity reasoning: The source metadata explicitly identifies the agency classification as 'Class I'. According to the severity rubric, an FDA Class I recall mandates a score of 5 (Critical), as it represents a reasonable probability of serious adverse health consequences.
Plain-English summary
Alcon Research, LTD. is recalling the CyPass System 241, Intraocular Pressure Lowering Implant, specifically the CYPASS MICRO-STENT and CYPASS APPLIER (REF: 8065754010). The recall involves 480 units distributed worldwide, including the United States, Puerto Rico, and numerous international locations. All lot and serial numbers are affected.
The recall was initiated after an analysis of the completed dataset from the COMPASS-XT long-term study indicated that the CyPass Micro-Stent group experienced statistically significant endothelial cell loss (ECL) compared to a group that underwent cataract surgery alone. This finding suggests a potential risk to eye health for patients who have received this specific implant.
Patients who have had the CyPass Micro-Stent implanted should contact their eye care provider to discuss these findings and determine the appropriate next steps for their care. The recall is classified as Class I by the FDA, indicating a reasonable probability that the use of, or exposure to, the violative product will cause serious adverse health consequences or death.
The recalled product
- Product
- CyPass System 241, Intraocular Pressure Lowering Implant, CYPASS MICRO-STENT, CYPASS APPLIER, REF: 8065754010. For ophthalmic use.
- Manufacturer
- Alcon Research, LTD.
- Hazard
- Affected units
- 480
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- GTIN 00380657540105 All lot/serial numbers
Distribution
Part of a larger recall action
This product is one of 4 recalled by Alcon Research, LTD. under a single FDA (Devices) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 4 products in this recall →Related recalls
Same manufacturer · Alcon Research, LTD.
See all →- SevereInfinity FMS Pak surgical device recalled for plastic debris hazard
FDA (Devices) · 2023-08-23
- SeverePhaco Standalone Tips Recalled Due to Plastic Debris Risk
FDA (Devices) · 2023-08-23
- SevereAlcon Custom Pak Intraocular Lens Packages Recalled for Plastic Debris Risk
FDA (Devices) · 2023-08-23
- SevereAlcon Constellation Procedure Pak recalled due to plastic debris risk
FDA (Devices) · 2023-08-23
- SevereLegion FMS Pak Surgical Instruments Recalled for Patient Injury from Plastic Debris
FDA (Devices) · 2023-08-23
Same hazard · endothelial cell loss
See all →- SevereAlcon Recalls CyPass Micro-Stent Due to Endothelial Cell Loss
FDA (Devices) · 2018-10-31
- HighAlcon Recalls CyPass Micro-Stent Due to Endothelial Cell Loss
FDA (Devices) · 2018-10-31
- HighAlcon Recalls CyPass Micro-Stent Implant Due to Endothelial Cell Loss
FDA (Devices) · 2018-10-31